Zobrazeno 1 - 10
of 174
pro vyhledávání: '"Jeffrey B. Ulmer"'
Autor:
Pierre-Gregoire Coulon, Swayam Prakash, Nisha R. Dhanushkodi, Ruchi Srivastava, Latifa Zayou, Delia F. Tifrea, Robert A. Edwards, Cesar J. Figueroa, Sebastian D. Schubl, Lanny Hsieh, Anthony B. Nesburn, Baruch D. Kuppermann, Elmostafa Bahraoui, Hawa Vahed, Daniel Gil, Trevor M. Jones, Jeffrey B. Ulmer, Lbachir BenMohamed
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
BackgroundCross-reactive SARS-CoV-2-specific memory CD4+ and CD8+ T cells are present in up to 50% of unexposed, pre-pandemic, healthy individuals (UPPHIs). However, the characteristics of cross-reactive memory CD4+ and CD8+ T cells associated with s
Externí odkaz:
https://doaj.org/article/cfccd8b8ca854d6b8000116b8e4549ef
Autor:
Swayam Prakash, Nisha R. Dhanushkodi, Latifa Zayou, Izabela Coimbra Ibraim, Afshana Quadiri, Pierre Gregoire Coulon, Delia F. Tifrea, Berfin Suzer, Amin Mohammed Shaik, Amruth Chilukuri, Robert A. Edwards, Mahmoud Singer, Hawa Vahed, Anthony B. Nesburn, Baruch D. Kuppermann, Jeffrey B. Ulmer, Daniel Gil, Trevor M. Jones, Lbachir BenMohamed
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
BackgroundThe coronavirus disease 2019 (COVID-19) pandemic has created one of the largest global health crises in almost a century. Although the current rate of Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections has decreased sig
Externí odkaz:
https://doaj.org/article/f12511c56f1e46ee92427f5132cbf3d9
Autor:
Jeffrey B. Ulmer, Margaret A. Liu
Publikováno v:
Molecular Frontiers Journal, Vol 05, Iss 01n02, Pp 38-57 (2021)
The rapid development of mRNA vaccines for COVID-19 has both astonished the world and raised concerns about their safety, perhaps because many people do not realize the decades’ long efforts for nucleic acid vaccines, both mRNA and DNA vaccines, in
Externí odkaz:
https://doaj.org/article/9abb33a6cad6403db4139cef2267115a
Autor:
Alvaro Baeza Garcia, Edwin Siu, Tiffany Sun, Valerie Exler, Luis Brito, Armin Hekele, Gib Otten, Kevin Augustijn, Chris J. Janse, Jeffrey B. Ulmer, Jürgen Bernhagen, Erol Fikrig, Andrew Geall, Richard Bucala
Publikováno v:
Nature Communications, Vol 9, Iss 1, Pp 1-13 (2018)
Plasmodium species produce an ortholog of the cytokine macrophage migration inhibitory factor, PMIF, which modulates the host inflammatory response to malaria. Here, the authors show that inhibition of PMIF may have translational benefits for managin
Externí odkaz:
https://doaj.org/article/be49eab245d7481c9136ee80bc91bed8
Publikováno v:
Expert Review of Vaccines, Vol 16, Iss 9, Pp 871-881 (2017)
Introduction: The present review summarizes the growing body of work defining the mechanisms of action of this exciting new vaccine technology that should allow rational approaches in the design of next generation mRNA vaccines. Areas covered: Bio-di
Externí odkaz:
https://doaj.org/article/af0fd2c6700e471485016843d9b2aaab
Autor:
Latifa Zayou, Swayam Prakash, Nisha R Dhanushkodi, Afshana Quadiri, Izabela Coimbra Ibraim, Mahmoud Singer, Amirah Salem, Amin Mohammed Shaik, Berfin Suzer, Amruth Chilukuri, Jennifer Tran, Pauline Chau Nguyen, Miyo Sun, Kathy K Hormi-Carver, Ahmed Belmouden, Hawa Vahed, Jeffrey B Ulmer, LBACHIR BENMOHAMED
The pandemic of the coronavirus disease 2019 (COVID-19) has created the largest global health crisis in almost a century. Following exposure to SARS-CoV-2, the virus particles replicate in the lungs, induce a cytokine storm and potentially cause life
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::52b3c43ab9da71891584169e920b5d61
https://doi.org/10.1101/2023.05.23.542024
https://doi.org/10.1101/2023.05.23.542024
Autor:
Swayam Prakash, Nisha R. Dhanushkodi, Latifa Zayou, Izabela Coimbra Ibraim, Afshana Quadiri, Pierre Gregoire Coulon, Delia F Tifrea, Berfin Suzler, Mohamed Amin, Amruth Chilukuri, Robert A Edwards, Hawa Vahed, Anthony B Nesburn, Baruch D Kuppermann, Jeffrey B. Ulmer, Daniel Gil, Trevor M. Jones, Lbachir BenMohamed
Publikováno v:
bioRxiv
BackgroundThe Coronavirus disease 2019 (COVID-19) pandemic has created one of the largest global health crises in almost a century. Although the current rate of SARS-CoV-2 infections has decreased significantly; the long-term outlook of COVID-19 rema
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1c3f12255ecbf30742aa3cee5fa8e139
https://europepmc.org/articles/PMC10245830/
https://europepmc.org/articles/PMC10245830/
Autor:
Giulietta Maruggi, Corey P. Mallett, Jason W. Westerbeck, Tiffany Chen, Giuseppe Lofano, Kristian Friedrich, Lin Qu, Jennifer Tong Sun, Josie McAuliffe, Amey Kanitkar, Kathryn T. Arrildt, Kai-Fen Wang, Ian McBee, Deborah McCoy, Rebecca Terry, Alison Rowles, Maia Araujo Abrahim, Michael A. Ringenberg, Malcolm J. Gains, Catherine Spickler, Xuping Xie, Jing Zou, Pei-Yong Shi, Taru Dutt, Marcela Henao-Tamayo, Izabela Ragan, Richard A. Bowen, Russell Johnson, Sandra Nuti, Kate Luisi, Jeffrey B. Ulmer, Ann-Muriel Steff, Rashmi Jalah, Sylvie Bertholet, Alan H. Stokes, Dong Yu
Publikováno v:
Molecular Therapy
RNA vaccines have demonstrated efficacy against SARS-CoV-2 in humans and the technology, is being leveraged for rapid emergency response. In this report, we assessed immunogenicity, and, for the first time, toxicity, biodistribution and protective ef
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6f8ac8597c1bbd871ec96b10ef6faf90
https://doi.org/10.1016/j.ymthe.2022.01.001
https://doi.org/10.1016/j.ymthe.2022.01.001
Autor:
Yingxia Wen, Hung V Trinh, Christine E Linton, Chiara Tani, Nathalie Norais, DeeAnn Martinez-Guzman, Priyanka Ramesh, Yide Sun, Frank Situ, Selen Karaca-Griffin, Christopher Hamlin, Sayali Onkar, Sai Tian, Susan Hilt, Padma Malyala, Rushit Lodaya, Ning Li, Gillis Otten, Giuseppe Palladino, Kristian Friedrich, Yukti Aggarwal, Celia LaBranche, Ryan Duffy, Xiaoying Shen, Georgia D Tomaras, David C Montefiori, William Fulp, Raphael Gottardo, Brian Burke, Jeffrey B Ulmer, Susan Zolla-Pazner, Hua-Xin Liao, Barton F Haynes, Nelson L Michael, Jerome H Kim, Mangala Rao, Robert J O'Connell, Andrea Carfi, Susan W Barnett
Publikováno v:
PLoS ONE, Vol 13, Iss 4, p e0194266 (2018)
The RV144 Phase III clinical trial with ALVAC-HIV prime and AIDSVAX B/E subtypes CRF01_AE (A244) and B (MN) gp120 boost vaccine regime in Thailand provided a foundation for the future development of improved vaccine strategies that may afford protect
Externí odkaz:
https://doaj.org/article/c524038f512c48a39e68e221debb900c
Publikováno v:
Expert opinion on drug discovery.
Prior to the emergence of SARS-CoV-2, the potential use of mRNA vaccines for a rapid pandemic response had been well described in the scientific literature, however during the SARS-CoV-2 outbreak we witnessed the large-scale deployment of the platfor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4dca0ae5d36546c9e79d7c98334fb90b
https://pubmed.ncbi.nlm.nih.gov/36384351
https://pubmed.ncbi.nlm.nih.gov/36384351